LifeSciVC

AUGUST 21, 2024

At this point of the year, the JPMorgan conference seems like ancient history and you are looking into flights for JPM 2025. This is especially true for rare disease trials with so few patients or trials involving patients with numerous concomitant or life-threatening conditions. These goals were believable and achievable.

Clinical Trials 81

Clinical Trials Trials Disease Treatment 81

BioPharma Drive: Drug Pricing

JUNE 9, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Sponsored The golden era of GLP-1 drugs: How will it impact medicine and society? As more people take them and their uses grow, so does their potential.

Clinical Trials 147

Clinical Trials Drugs Therapies Clinical Supply 147

BioPharma Drive: Drug Pricing

JUNE 5, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from FDA’s AI tool ‘Elsa’ is here, and the industry has questions The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool’s rollout.

FDA 130

FDA Therapies Clinical Supply Licensing 130

BioPharma Drive: Drug Pricing

JUNE 9, 2025

From pioneering treatments for rare pediatric diseases to exploring natural killer cells for Alzheimers and developing FDA-approved digital therapeutics for fibromyalgia, each episode reveals the scientific ingenuity and personal determination behind medical advances. ⬆ Ep. 1 Pioneering Treatments for Rare Pediatric Diseases Ep.

Trials 130

Trials Clinical Supply Clinical Trials Therapies 130